IONIS-FGFR4Rx is under investigation in clinical trial NCT02476019 (A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients).
Translational Research Institute for Metabolism and Diabetes, Orlando, Florida, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.